Volume 7 Issue 6
Nov.  2016
Turn off MathJax
Article Contents

doi: 10.3969/j.issn.1674-9081.2016.06.010
  • Received Date: 2014-10-27
  • Publish Date: 2016-11-30
  • loading
  • [1] Deguchi M, Isobe Y, Matsukawa S, et al. Usefulness of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress[J]. Surgery, 1998, 123:440-449. doi:  10.1016/S0039-6060(98)70166-7
    [2] Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance[J]. Anesthesiology, 2007, 106:499-506. doi:  10.1097/00000542-200703000-00014
    [3] Bar-Yosef S, Melamed R, Page GG, et al. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats[J]. Anesthesiology, 2001, 94:1066-1073. doi:  10.1097/00000542-200106000-00022
    [4] Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?[J]. Anesthesiology, 2006, 105:660-664. doi:  10.1097/00000542-200610000-00008
    [5] Biki B, Mascha E, Moriarty DC, et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence:a retrospective analysis[J]. Anesthesiology, 2008, 109:180-187. doi:  10.1097/ALN.0b013e31817f5b73
    [6] Christopherson R, James KE, Tableman M, et al. Long-term survival after colon cancer surgery:a variation associated with choice of anesthesia[J]. Anesth Analg, 2008, 107:325-332. doi:  10.1213/ane.0b013e3181770f55
    [7] Wang P, Chen J, Mu LH, et al. Propofol inhibits invasion and enhances paclitaxel-induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug[J]. Eur Rev Med Pharmacol Sci, 2013, 17:1722-1729. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=4a03eda7ab9e4119ccf9d480a34cc492
    [8] Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice[J]. Immuno-pharmacol Immunotoxicol, 2007, 29:477-486. doi:  10.1080/08923970701675085
    [9] Siddiqui RA, Zerouga M, Wu M, et al. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells[J]. Breast Cancer Res, 2005, 7:R645-R654. doi:  10.1186/bcr1036
    [10] Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth[J]. Cancer Res, 2002, 62:4491-4498. http://bja.oxfordjournals.org/lookup/ijlink?linkType=ABST&journalCode=canres&resid=62/15/4491
    [11] Fuggetta MP, Di Francesco P, Falchetti R, et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells[J]. J Exp Clin Cancer Res, 2005, 24:255-263. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a059b21ee4d0e3540c43d9938f1d3ff6
    [12] Cadet P, Mantione KJ, Stefano GB. Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene[J]. J Immunol, 2003, 170:5118-5123. doi:  10.4049/jimmunol.170.10.5118
    [13] Sueoka E, Sueoka N, Kai Y, et al. Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation[J]. Biochem Biophys Res Commun, 1998, 252:566-570. doi:  10.1006/bbrc.1998.9695
    [14] Shavit Y, Ben-Eliyahu S, Zeidel A, et al. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study[J]. Neuroimmunomodulation, 2004, 11:255-260. doi:  10.1159/000078444
    [15] Yeager MP, Procopio MA, DeLeo JA, et al. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans[J]. Anesth Analg, 2002, 94:94-99. http://www.ncbi.nlm.nih.gov/pubmed/11772808
    [16] Jacobs R, Karst M, Scheinichen D, et al. Effects of fentanyl on cellular immune functions in man[J]. Int J Immuno-pharmacol, 1999, 21:445-454. doi:  10.1016/S0192-0561(99)00025-9
    [17] Indad T, Shirane A, Hamano N, et al. Effect of subhypnotic doses of dexmedetomidine on antitumor immunity in mice[J]. Immunopharmacol Immunotoxicol, 2005, 27:357-369. doi:  10.1080/08923970500240883
    [18] van Meurs M, Wulfert FM, Jongman RM, et al. Hemorrha-gic shock-induced endothelial cell activation in a spontaneous breathing and a mechanical ventilation hemorrhagic shock model is induced by a proinflammatory response and not by hypoxia[J]. Anesthesiology, 2011, 115:474-482. doi:  10.1097/ALN.0b013e318229a640
    [19] Eltzschig HK, Carmeliet P. Hypoxia and inflammation[J]. N Engl J Med, 2011, 364:656-665. doi:  10.1056/NEJMra0910283
    [20] Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases[J]. Ann Surg, 1991, 214:107-113. doi:  10.1097/00000658-199108000-00003
    [21] Yi J, Xiang Z, Deng X, et al. Incidence of inadvertent intraoperative hypothermia and its risk factors in patients undergoing general anesthesia in Beijing:a prospective regional survey[J]. PLoS One, 2015, 10:e0136136. doi:  10.1371/journal.pone.0136136
    [22] Ben-Eliyahu S, Shakhar G, Rosenne E, et al. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis:a role for adrenergic mechanisms[J]. Anesthesiology, 1999, 91:732-740. doi:  10.1097/00000542-199909000-00026
    [23] Beilin B, Shavit Y, Razumovsky J, et al. Effects of mild perioperative hypothermia on cellular immune responses[J]. Anesthesiology, 1998, 89:1133-1140. doi:  10.1097/00000542-199811000-00013
    [24] Hosokawa T, Kurosaki M, Tsuchiya K, et al. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy[J]. World J Gastroenterol, 2013, 19:249-257. doi:  10.3748/wjg.v19.i2.249
    [25] Wright JL, Plymate SR, Porter MP, et al. Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer[J].Prostate Cancer Prostatic Dis, 2013, 16:204-208. doi:  10.1038/pcan.2013.5
    [26] Abel EJ, Linder BJ, Bauman TM, et al. Perioperative blood transfusion and radical cystectomy:does timing of transfusion affect bladder cancer mortality?[J]. Eur Urol, 2014, 66:1139-1147. doi:  10.1016/j.eururo.2014.08.051
    [27] Luan H, Ye F, Wu L, et al. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer:a systematic review and a meta-analysis[J]. BMC Surg, 2014, 14:34. doi:  10.1186/1471-2482-14-34
    [28] Gunka I, Dostalik J, Martinek L, et al. Impact of blood transfusions on survival and recurrence in colorectal cancer surgery[J]. Indian J Surg, 2013, 75:94-101. doi:  10.1007/s12262-012-0427-6
    [29] Liu L, Wang Z, Jiang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma:a meta-analysis[J]. PLoS One, 2013, 8:e64261. doi:  10.1371/journal.pone.0064261
    [30] Boehm K, Beyer B, Tennstedt P, et al. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer[J]. World J Urol, 2015, 33:801-806. doi:  10.1007/s00345-014-1351-0
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (130) PDF downloads(4) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint